JP2001252100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001252100A5 JP2001252100A5 JP2000065486A JP2000065486A JP2001252100A5 JP 2001252100 A5 JP2001252100 A5 JP 2001252100A5 JP 2000065486 A JP2000065486 A JP 2000065486A JP 2000065486 A JP2000065486 A JP 2000065486A JP 2001252100 A5 JP2001252100 A5 JP 2001252100A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- solid phase
- phase carrier
- present
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 description 108
- 102000039446 nucleic acids Human genes 0.000 description 108
- 150000007523 nucleic acids Chemical class 0.000 description 108
- 239000007790 solid phase Substances 0.000 description 34
- 239000000126 substance Substances 0.000 description 26
- 238000000605 extraction Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 238000000746 purification Methods 0.000 description 18
- 239000006249 magnetic particle Substances 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 238000005406 washing Methods 0.000 description 13
- 239000012472 biological sample Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 150000002989 phenols Chemical class 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 229910044991 metal oxide Inorganic materials 0.000 description 5
- 150000004706 metal oxides Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 239000007984 Tris EDTA buffer Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229960000633 dextran sulfate Drugs 0.000 description 4
- 238000001821 nucleic acid purification Methods 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 125000005372 silanol group Chemical group 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 239000006172 buffering agent Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
- 229940051593 dermatan sulfate Drugs 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- -1 for example Chemical class 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- VHJLVAABSRFDPM-IMJSIDKUSA-N L-1,4-dithiothreitol Chemical compound SC[C@H](O)[C@@H](O)CS VHJLVAABSRFDPM-IMJSIDKUSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 229910020175 SiOH Inorganic materials 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- MWWQKLKFKPWECK-UHFFFAOYSA-N aminomethanetriol;hydrochloride Chemical compound Cl.NC(O)(O)O MWWQKLKFKPWECK-UHFFFAOYSA-N 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000065486A JP4519247B2 (ja) | 2000-03-09 | 2000-03-09 | 核酸の抽出精製用試薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000065486A JP4519247B2 (ja) | 2000-03-09 | 2000-03-09 | 核酸の抽出精製用試薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001252100A JP2001252100A (ja) | 2001-09-18 |
| JP2001252100A5 true JP2001252100A5 (enExample) | 2007-04-19 |
| JP4519247B2 JP4519247B2 (ja) | 2010-08-04 |
Family
ID=18585008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000065486A Expired - Fee Related JP4519247B2 (ja) | 2000-03-09 | 2000-03-09 | 核酸の抽出精製用試薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4519247B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8426126B2 (en) * | 2004-03-18 | 2013-04-23 | Applied Biosystems, Llc | Modified surfaces as solid supports for nucleic acid purification |
| US8357672B2 (en) * | 2008-06-13 | 2013-01-22 | Bio-Rad Laboratories, Inc. | Cell lysis reagent for isolation of RNA |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2054797T3 (es) * | 1987-03-02 | 1994-08-16 | Gen Probe Inc | Soportes policationicos para purificar, separar e hibridar acidos nucleicos. |
| JP3044819B2 (ja) * | 1990-05-17 | 2000-05-22 | 住友電気工業株式会社 | 全核酸中の特定の核酸断片の抽出法 |
| ES2194843T3 (es) * | 1992-09-11 | 2003-12-01 | Hoffmann La Roche | Deteccion de acidos nucleicos en sangre. |
| JPH0720130A (ja) * | 1993-07-05 | 1995-01-24 | Chisso Corp | 微量物質を検出する方法および器具 |
| JP4134351B2 (ja) * | 1994-06-22 | 2008-08-20 | Ｊｓｒ株式会社 | 核酸結合用粒子担体 |
| US5707799A (en) * | 1994-09-30 | 1998-01-13 | Abbott Laboratories | Devices and methods utilizing arrays of structures for analyte capture |
| JP2965131B2 (ja) * | 1995-07-07 | 1999-10-18 | 東洋紡績株式会社 | 核酸結合用磁性担体およびそれを用いる核酸単離方法 |
| JPH11165066A (ja) * | 1997-12-02 | 1999-06-22 | Masashi Funayama | リポ多糖、核酸および微生物の吸着体 |
| JPH11236506A (ja) * | 1998-02-23 | 1999-08-31 | Jsr Corp | 磁性粒子、磁性粒子の製造方法および非特異性核酸結合担体 |
-
2000
- 2000-03-09 JP JP2000065486A patent/JP4519247B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tan et al. | DNA, RNA, and protein extraction: the past and the present | |
| JP4175670B2 (ja) | 固体相核酸の単離 | |
| JP4291247B2 (ja) | 核酸を単離する方法 | |
| US5596092A (en) | Extraction of genomic DNA from blood using cationic detergents | |
| US5990302A (en) | Method for isolating ribonucleic acid | |
| JP2002502856A (ja) | 核酸の単離および精製方法 | |
| JP2002187897A (ja) | 二本鎖／単鎖核酸構造物の分離方法 | |
| JPH08501321A (ja) | クロマトグラフィーによる核酸混合物の精製分離法 | |
| AU1633199A (en) | Methods of nucleic acid isolation | |
| JPH09327291A (ja) | Ｒｎａの抽出精製方法 | |
| EP1590488A2 (en) | Chemical treatment of biological samples for nucleic acid extraction and kits therefor | |
| JP6431522B2 (ja) | 核酸の精製のための１工程法 | |
| WO2004108925A1 (en) | Method for sequentially isolating dna and rna from the same nucleic acid-containing sample | |
| JP3940935B2 (ja) | プラスミドｄｎａの抽出精製方法 | |
| US20030229222A1 (en) | Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid | |
| JP3812696B2 (ja) | リボ核酸の抽出方法 | |
| CN106232812A (zh) | 短链核酸的回收方法 | |
| JP3082908B2 (ja) | リボ核酸の単離方法 | |
| JP2003062401A (ja) | 生体物質の精製方法および精製装置 | |
| JP4198461B2 (ja) | シラン処理シリカ基質を用いた溶解物クリアランスおよび核酸単離 | |
| JP4519247B2 (ja) | 核酸の抽出精製用試薬 | |
| JP2001252100A5 (enExample) | ||
| WO2009040444A1 (en) | Rna isolation method | |
| RU2808832C1 (ru) | Способ выделения рибонуклеиновой кислоты вируса из спинномозговой жидкости для молекулярно-биологических исследований | |
| WO1997030152A1 (en) | Separation of single stranded and double stranded nucleic acid materials |